Active Pharmaceutical Ingredient (API) Market Report

Global and Region Active Pharmaceutical Ingredient (API) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：197
  • REPORT CODE：GMM900877
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Active Pharmaceutical Ingredient (API) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Active Pharmaceutical Ingredient (API)market, defines the market attractiveness level of Active Pharmaceutical Ingredient (API) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Active Pharmaceutical Ingredient (API) industry, describes the types of Active Pharmaceutical Ingredient (API) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Active Pharmaceutical Ingredient (API) market and the development prospects and opportunities of Active Pharmaceutical Ingredient (API) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Active Pharmaceutical Ingredient (API) market in Chapter 13.

    By Player:

    • Teva

    • Sun Pharmaceutical

    • Aurobindo Pharma

    • Albemarle

    • Sigma-Aldrich

    • Mylan

    • Allergan

    By Type:

    • Innovative APIS Segment

    • Generic APIS Segment

    By End-User:

    • Oncology

    • Diabetes

    • Cardiovascular Disease

    • Cns and Neurological Disorders

    • Orthopedic Disorders

    • Nephrology

    • Ophthalmology

    • Pulmonology

    • Gastrointestinal Disorders

    • Endocrinology

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Active Pharmaceutical Ingredient (API) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Active Pharmaceutical Ingredient (API) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Active Pharmaceutical Ingredient (API) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Active Pharmaceutical Ingredient (API) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Active Pharmaceutical Ingredient (API) Market Analysis and Outlook to 2022

    • 7.1 Global Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

    • 7.2 United States Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

    • 7.3 Europe Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

    • 7.4 China Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

    • 7.5 Japan Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

    • 7.6 India Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

    • 7.7 South Korea Active Pharmaceutical Ingredient (API) Consumption (2017-2022)

    8 Region and Country-wise Active Pharmaceutical Ingredient (API) Market Analysis and Outlook to 2028

    • 8.1 Global Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

    • 8.2 United States Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

    • 8.3 Europe Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

    • 8.4 China Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

    • 8.5 Japan Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

    • 8.6 India Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

    • 8.7 South Korea Active Pharmaceutical Ingredient (API) Consumption Forecast (2022-2028)

    9 Global Active Pharmaceutical Ingredient (API) Market Outlook by Types and Applications to 2022

    • 9.1 Global Active Pharmaceutical Ingredient (API) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Innovative APIS Segment Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Generic APIS Segment Consumption and Growth Rate (2017-2022)

    • 9.2 Global Active Pharmaceutical Ingredient (API) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Diabetes Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Cardiovascular Disease Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Cns and Neurological Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Orthopedic Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Nephrology Consumption and Growth Rate (2017-2022)

      • 9.2.7 Global Ophthalmology Consumption and Growth Rate (2017-2022)

      • 9.2.8 Global Pulmonology Consumption and Growth Rate (2017-2022)

      • 9.2.9 Global Gastrointestinal Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.10 Global Endocrinology Consumption and Growth Rate (2017-2022)

    10 Global Active Pharmaceutical Ingredient (API) Market Outlook by Types and Applications to 2028

    • 10.1 Global Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Innovative APIS Segment Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Generic APIS Segment Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Cardiovascular Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Cns and Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Orthopedic Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global Nephrology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.7 Global Ophthalmology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.8 Global Pulmonology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.9 Global Gastrointestinal Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.10 Global Endocrinology Consumption Forecast and Growth Rate (2022-2028)

    11 Global Active Pharmaceutical Ingredient (API) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Active Pharmaceutical Ingredient (API) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Active Pharmaceutical Ingredient (API) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Active Pharmaceutical Ingredient (API) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Active Pharmaceutical Ingredient (API) Market Competitive Analysis

    • 14.1 Teva

      • 14.1.1 Teva Company Details

      • 14.1.2 Teva Active Pharmaceutical Ingredient (API) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Teva Active Pharmaceutical Ingredient (API) Product and Service

    • 14.2 Sun Pharmaceutical

      • 14.2.1 Sun Pharmaceutical Company Details

      • 14.2.2 Sun Pharmaceutical Active Pharmaceutical Ingredient (API) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Sun Pharmaceutical Active Pharmaceutical Ingredient (API) Product and Service

    • 14.3 Aurobindo Pharma

      • 14.3.1 Aurobindo Pharma Company Details

      • 14.3.2 Aurobindo Pharma Active Pharmaceutical Ingredient (API) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Aurobindo Pharma Active Pharmaceutical Ingredient (API) Product and Service

    • 14.4 Albemarle

      • 14.4.1 Albemarle Company Details

      • 14.4.2 Albemarle Active Pharmaceutical Ingredient (API) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Albemarle Active Pharmaceutical Ingredient (API) Product and Service

    • 14.5 Sigma-Aldrich

      • 14.5.1 Sigma-Aldrich Company Details

      • 14.5.2 Sigma-Aldrich Active Pharmaceutical Ingredient (API) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Sigma-Aldrich Active Pharmaceutical Ingredient (API) Product and Service

    • 14.6 Mylan

      • 14.6.1 Mylan Company Details

      • 14.6.2 Mylan Active Pharmaceutical Ingredient (API) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Mylan Active Pharmaceutical Ingredient (API) Product and Service

    • 14.7 Allergan

      • 14.7.1 Allergan Company Details

      • 14.7.2 Allergan Active Pharmaceutical Ingredient (API) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Allergan Active Pharmaceutical Ingredient (API) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Active Pharmaceutical Ingredient (API)

    • Figure Active Pharmaceutical Ingredient (API) Picture

    • Table Global Active Pharmaceutical Ingredient (API) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Active Pharmaceutical Ingredient (API) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Active Pharmaceutical Ingredient (API) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Active Pharmaceutical Ingredient (API) Consumption by Country (2017-2022)

    • Figure United States Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Table Europe Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure China Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Japan Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure India Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Global Active Pharmaceutical Ingredient (API) Consumption Forecast by Country (2022-2028)

    • Figure United States Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Innovative APIS Segment Consumption and Growth Rate (2017-2022)

    • Figure Global Generic APIS Segment Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Diabetes Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiovascular Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Cns and Neurological Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Orthopedic Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Nephrology Consumption and Growth Rate (2017-2022)

    • Figure Global Ophthalmology Consumption and Growth Rate (2017-2022)

    • Figure Global Pulmonology Consumption and Growth Rate (2017-2022)

    • Figure Global Gastrointestinal Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Endocrinology Consumption and Growth Rate (2017-2022)

    • Figure Global Innovative APIS Segment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Generic APIS Segment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiovascular Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cns and Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Orthopedic Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nephrology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ophthalmology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pulmonology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gastrointestinal Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Endocrinology Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Active Pharmaceutical Ingredient (API) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Active Pharmaceutical Ingredient (API) Export by Region (Top 5 Countries) (2017-2028)

    • Table Teva (Foundation Year, Company Profile and etc.)

    • Table Teva Active Pharmaceutical Ingredient (API) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Active Pharmaceutical Ingredient (API) Product and Service

    • Table Sun Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Sun Pharmaceutical Active Pharmaceutical Ingredient (API) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharmaceutical Active Pharmaceutical Ingredient (API) Product and Service

    • Table Aurobindo Pharma (Foundation Year, Company Profile and etc.)

    • Table Aurobindo Pharma Active Pharmaceutical Ingredient (API) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aurobindo Pharma Active Pharmaceutical Ingredient (API) Product and Service

    • Table Albemarle (Foundation Year, Company Profile and etc.)

    • Table Albemarle Active Pharmaceutical Ingredient (API) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Albemarle Active Pharmaceutical Ingredient (API) Product and Service

    • Table Sigma-Aldrich (Foundation Year, Company Profile and etc.)

    • Table Sigma-Aldrich Active Pharmaceutical Ingredient (API) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sigma-Aldrich Active Pharmaceutical Ingredient (API) Product and Service

    • Table Mylan (Foundation Year, Company Profile and etc.)

    • Table Mylan Active Pharmaceutical Ingredient (API) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Active Pharmaceutical Ingredient (API) Product and Service

    • Table Allergan (Foundation Year, Company Profile and etc.)

    • Table Allergan Active Pharmaceutical Ingredient (API) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Active Pharmaceutical Ingredient (API) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US